FDA Principal Deputy Commissioner Namandjé Bumpus, PhD, is stepping down from her role, marking one of the first significant leadership departures at the agency by the end of year, Inside Health Policy reported Dec. 17.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
